دورية أكاديمية

Long-term physiological T3 supplementation in hypertensive heart disease in rats.

التفاصيل البيبلوغرافية
العنوان: Long-term physiological T3 supplementation in hypertensive heart disease in rats.
المؤلفون: Weltman, Nathan Y., Pol, Christine J., Youhua Zhang, Yibo Wang, Koder, Adrienne, Raza, Sarah, Zucchi, Riccardo, Saba, Alessandro, Colligiani, Daria, Gerdes, A. Martin
المصدر: American Journal of Physiology: Heart & Circulatory Physiology; 2015, Vol. 309 Issue 6, pH1059-H1065, 7p, 6 Graphs
مصطلحات موضوعية: HYPERTENSIVE crisis, ANIMAL models in research, HEART diseases, LABORATORY rats, HEART failure, THYROID hormones
مستخلص: Animal studies suggest that hypertension leads to cardiac tissue hypothyroidism, a condition that can by itself lead to heart failure. We have previously shown that short-term thyroid hormone treatment in Spontaneously Hypertensive Heart Failure (SHHF) rats near heart failure is beneficial. This study tested the hypothesis that therapeutic, long-term T3 treatment in SHHF rats can prevent or attenuate cardiac dysfunction. Female SHHF rats were treated orally with a physiological T3 dose (0.04 μg/ml) from 12 to 24 mo of age. Age-matched female SHHF and Wistar-Kyoto rats served as hypertensive and normotensive controls, respectively. SHHF rats had reduced serum free thyroid hormone levels and cardiac tissue T3 levels, LV dysfunction, and elevated LV collagen content compared with normotensive controls. Restoration of serum and cardiac tissue thyroid hormone levels in T3-treated rats was associated with no change in heart rate, but strong trends for improvement in LV systolic function and collagen levels. For instance, end-systolic diameter, fractional shortening, systolic wall stress, and LV collagen levels were no longer significantly different from controls. In conclusion, longstanding hypertension in rats led to chronic low serum and cardiac tissue thyroid hormone levels. Long-term treatment with low-dose T3 was safe. While cardiac dysfunction could not be completely prevented in the absence of antihypertensive treatment, T3 may offer additional benefits as an adjunct therapy with possible improvement in diastolic function. [ABSTRACT FROM AUTHOR]
Copyright of American Journal of Physiology: Heart & Circulatory Physiology is the property of American Physiological Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03636135
DOI:10.1152/ajpheart.00431.2015